These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 6403136)

  • 21. Clinically significant drug interactions with antituberculosis agents.
    Grange JM; Winstanley PA; Davies PD
    Drug Saf; 1994 Oct; 11(4):242-51. PubMed ID: 7848544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pathogenetic therapy of pulmonary tuberculosis in adolescents].
    Pavlova MV
    Probl Tuberk; 1994; (3):19-21. PubMed ID: 7937663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The influence of rifampicin upon the metabolism of isoniazid (author's transl)].
    Modai J; Coulaud JP; Vivien JM; Berthelot G; Bergogne-Berezin E
    Nouv Presse Med; 1978 Apr; 7(15):1263-7. PubMed ID: 662655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The clearance of theophylline is increased during the initial period of tuberculosis treatment.
    Ahn HC; Lee YC
    Int J Tuberc Lung Dis; 2003 Jun; 7(6):587-91. PubMed ID: 12797703
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rifampicin has a profound effect on the pharmacokinetics of oral S-ketamine and less on intravenous S-ketamine.
    Peltoniemi MA; Saari TI; Hagelberg NM; Laine K; Kurkinen KJ; Neuvonen PJ; Olkkola KT
    Basic Clin Pharmacol Toxicol; 2012 Nov; 111(5):325-32. PubMed ID: 22676424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetic interactions between efavirenz and rifampicin in HIV-infected patients with tuberculosis.
    López-Cortés LF; Ruiz-Valderas R; Viciana P; Alarcón-González A; Gómez-Mateos J; León-Jimenez E; Sarasanacenta M; López-Pua Y; Pachón J
    Clin Pharmacokinet; 2002; 41(9):681-90. PubMed ID: 12126459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pharmacokinetics of rifampicin in patients with pulmonary tuberculosis].
    Gol'dshteĭn VD; Ioffe RA; Kriukov VL
    Probl Tuberk; 1977 Apr; (4):61-6. PubMed ID: 877065
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of rifampicin administration on theophylline pharmacokinetics in humans.
    Powell-Jackson PR; Jamieson AP; Gray BJ; Moxham J; Williams R
    Am Rev Respir Dis; 1985 Jun; 131(6):939-40. PubMed ID: 4003946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Time course of the changes in prednisolone pharmacokinetics after co-administration or discontinuation of rifampin.
    Lee KH; Shin JG; Chong WS; Kim S; Lee JS; Jang IJ; Shin SG
    Eur J Clin Pharmacol; 1993; 45(3):287-9. PubMed ID: 8276057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparative study on the pharmacokinetics of rifampicin between the old and middle-aged tuberculosis patients].
    Weng FH
    Zhonghua Jie He He Hu Xi Za Zhi; 1990 Oct; 13(5):292-4, 319. PubMed ID: 2085859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Liver function in patients with chronic destructive pulmonary tuberculosis during complex treatment with rifampicin and ethambutol].
    Kharakter ZhZ; Chertkova MA; Pavlenko AV
    Probl Tuberk; 1975; (10):44-8. PubMed ID: 1208440
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect of ethambutol and rifampicin on sputum conversion in chronically infectious patients].
    Juchniewicz M; Radecki A; Kowalczyk H; Grzywacz W
    Gruzlica; 1974 May; 42(5):397-400. PubMed ID: 4464226
    [No Abstract]   [Full Text] [Related]  

  • 33. Rifampicin seems to act as both an inducer and an inhibitor of the metabolism of repaglinide.
    Bidstrup TB; Stilling N; Damkier P; Scharling B; Thomsen MS; Brøsen K
    Eur J Clin Pharmacol; 2004 Apr; 60(2):109-14. PubMed ID: 15034704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].
    Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug interaction between rifampicin and cotrimoxazole in patients with tuberculosis.
    Bhatia RS; Uppal R; Malhi R; Behera D; Jindal SK
    Hum Exp Toxicol; 1991 Nov; 10(6):419-21. PubMed ID: 1687853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Markers of gut dysfunction do not explain low rifampicin bioavailability in HIV-associated TB.
    Vinnard C; Ravimohan S; Tamuhla N; Pasipanodya J; Srivastava S; Modongo C; Zetola NM; Weissman D; Gumbo T; Bisson GP
    J Antimicrob Chemother; 2017 Jul; 72(7):2020-2027. PubMed ID: 28472448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetic Evaluation of the Interactions of Amenamevir (ASP2151) with Ketoconazole, Rifampicin, Midazolam, and Warfarin in Healthy Adults.
    Kusawake T; den Adel M; Groenendaal-van de Meent D; Garcia-Hernandez A; Takada A; Kato K; Ohtsu Y; Katashima M
    Adv Ther; 2017 Nov; 34(11):2466-2480. PubMed ID: 29076107
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Reactivation of pulmonary tuberculosis in patients treated with rifampicin and ethambutol].
    Kuznetsova ZA
    Probl Tuberk; 1985; (12):40-2. PubMed ID: 4095097
    [No Abstract]   [Full Text] [Related]  

  • 39. [Rifampicin, pregnancy, hormonal contraception, menopause and aging].
    Rocher G; Haour P; Viallier J; Bouvy F; Van Theemsche G
    Rev Tuberc Pneumol (Paris); 1971 Nov; 35(7):695-712. PubMed ID: 5151212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and efficacy of levofloxacin versus rifampicin in tuberculous meningitis: an open-label randomized controlled trial.
    Kalita J; Misra UK; Prasad S; Bhoi SK
    J Antimicrob Chemother; 2014 Aug; 69(8):2246-51. PubMed ID: 24752957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.